News|Articles|September 13, 2026

FAQ: Congenital Measles

Congenital measles is a serious infection that can occur when a pregnant woman contracts measles near delivery and transmits the virus across the placenta to her newborn. Here is more information around this rare form of the disease.

Measles is one of the most contagious viruses known, spread through respiratory droplets and airborne particles that can linger in a room for up to two hours after an infected person has left.1 While most people associate measles with childhood illness, the virus can also cross the placenta and infect a fetus when a pregnant woman becomes infected — a condition known as congenital or perinatal measles. This form of the disease is rare in countries with high vaccination coverage, but clinicians are seeing it resurface as measles outbreaks spread through communities with declining MMR (measles, mumps, and rubella) vaccination rates.2,3

Related to this article

FAQ: Shamonda Virus
As France confirms the first documented human Shamonda virus infection, a fatal encephalitis in a stem cell transplant recipient, this FAQ explains what the virus is, where it has spread, how the case was diagnosed, how the patient was likely infected and what clinicians should watch for.
ID Week Highlights Part 1
In this first IDWeek 2026 roundup, oral olorofim matched AmBisome in invasive aspergillosis, aztreonam-avibactam held activity as MBL-producing CRE rose, pritelivir cut hospitalizations in refractory HSV, and zelicapavir shortened RSV symptoms in high-risk adults.
Pfizer 25-Valent Pneumococcal Vaccine Boosts Serotype 3 Response in Infants
Alejandra Gurtman, MD, discussed the phase 2 data at IDWeek 2026 which showed the investigational 25-valent pneumococcal conjugate vaccine 25vPnC produced serotype 3 antibody levels about 15-fold higher than Prevnar 20 after the booster dose, targeting a serotype still behind 10.6% of invasive pneumococcal disease in US children younger than five years.